The bipartisan legislation rolled back federal restrictions on medical Cannabis research and the cultivation of research-grade marijuana, as well as promote the development of US Food and Drug Administration (FDA)-approved drugs that use cannabidiol (CBD) and Cannabis. Read more about the Medical Marijuana Research Act H.R.5657.